Spinal Tumor Drug Just Cleared A Major FDA Hurdle
A drug called plixorafenib just received Breakthrough Therapy Designation from the FDA for treating a specific type of aggressive brain and spinal cord tumor, and the reason the designation was granted is
Follow Us